BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32792228)

  • 41. Cardiothoracic manifestations of Erdheim-Chester disease.
    Das JP; Xie L; Riedl CC; Hayes SA; Ginsberg MS; Halpenny DF
    Br J Radiol; 2019 Dec; 92(1104):20190473. PubMed ID: 31386554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
    Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MR/PET: a new challenge in hybrid imaging.
    Werner MK; Schmidt H; Schwenzer NF
    AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/MR Imaging in Musculoskeletal Precision Imaging - Third wave after X-Ray and MR.
    Hancin EC; Borja AJ; Nikpanah M; Raynor WY; Haldar D; Werner TJ; Morris MA; Saboury B; Alavi A; Gholamrezanezhad A
    PET Clin; 2020 Oct; 15(4):521-534. PubMed ID: 32768369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET/MR Imaging in Musculoskeletal Disorders.
    Andersen KF; Jensen KE; Loft A
    PET Clin; 2016 Oct; 11(4):453-63. PubMed ID: 27593249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18-Fluoro-deoxyglucose-PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders: Value to Patient Management.
    Basu S; Ranade R
    PET Clin; 2015 Jul; 10(3):431-9. PubMed ID: 26099677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
    Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
    Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Advances in Computed Tomographic Technology: Cardiopulmonary Imaging Applications.
    Tabari A; Lo Gullo R; Murugan V; Otrakji A; Digumarthy S; Kalra M
    J Thorac Imaging; 2017 Mar; 32(2):89-100. PubMed ID: 28221262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Advances in Imaging of Small and Large Bowel.
    Das CJ; Manchanda S; Panda A; Sharma A; Gupta AK
    PET Clin; 2016 Jan; 11(1):21-37. PubMed ID: 26590441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applications of PET-MR Imaging in Cardiovascular Disorders.
    Cardoso R; Leucker TM
    PET Clin; 2020 Oct; 15(4):509-520. PubMed ID: 32888548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
    Wilk B; Wisenberg G; Dharmakumar R; Thiessen JD; Goldhawk DE; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2083-2099. PubMed ID: 31797321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
    Paul NS; Ley S; Metser U
    Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Practical Considerations for Clinical PET/MR Imaging.
    Galgano S; Viets Z; Fowler K; Gore L; Thomas JV; McNamara M; McConathy J
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):281-296. PubMed ID: 28390529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MR-based attenuation correction for cardiac FDG PET on a hybrid PET/MRI scanner: comparison with standard CT attenuation correction.
    Vontobel J; Liga R; Possner M; Clerc OF; Mikulicic F; Veit-Haibach P; Ter Voert EE; Fuchs TA; Stehli J; Pazhenkottil AP; Benz DC; Gräni C; Gaemperli O; Herzog B; Buechel RR; Kaufmann PA
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1574-80. PubMed ID: 26091704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.